XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (523) $ (14,271)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on equity investments 1,781  
Noncash revenue from equity investments (5) (46)
Fair value adjustments (24,824) 3,079
Depreciation 887 877
Stock-based compensation 4,366 1,775
Noncash research and development expenses 498 435
Noncash investment accretion 1,955 83
Loss on disposal of property and equipment 19  
Decrease (increase) in assets:    
Accounts receivable, net 20,153 2,404
Unbilled and other receivables (3,065) 5,154
Reduction in the carrying amount of right of use assets 1,264 1,299
Prepaid expenses and other assets (3,549) (1,106)
Increase (decrease) in liabilities:    
Accounts payable (1,230) 2,110
Accrued payroll, taxes, and benefits (1,655) (2,289)
Deferred revenue (8,447) (3,378)
Lease liabilities (1,352) (1,266)
Other accrued liabilities 2,806 (638)
Net cash used in operating activities (10,921) (5,778)
Cash flows from investing activities:    
Purchases of property and equipment (513) (843)
Purchases of equity investments   (2,869)
Distribution from equity investment 40  
Proceeds from sale of equity investments 15,735  
Purchases of marketable securities (143,671) (127,109)
Proceeds from maturity of marketable securities 66,500 42,908
Net cash used in investing activities (61,909) (87,913)
Cash flows from financing activities:    
Issuances of common stock upon initial public offering, net   212,277
Issuances of common stock upon stock option exercises 3,656 177
Net cash provided by financing activities 3,656 212,454
Net (decrease) increase in cash and cash equivalents and restricted cash (69,174) 118,763
Cash and cash equivalents and restricted cash, beginning of period 202,796 26,486
Cash and cash equivalents and restricted cash, end of period 133,622 145,249
Supplemental disclosure of cash flow and noncash information    
Cash paid for income taxes 119 64
Supplemental disclosure of non-cash investing and financing activities    
Payment of deferred offering costs   786
Purchases of property and equipment $ 52 254
Acquisitions of right of use assets in exchange for lease obligations   1,778
Reclassification of deferred financing costs to additional paid in capital   $ 1,858